News

Insights on concierge medicine, direct primary care, and personalized healthcare.

OpenEvidence Is Now Valued at 15 Billion Dollars

OpenEvidence has reached a reported $15 billion valuation after raising another $250 million . Andreessen Horowitz and Byers Capital led the round, which founder and CEO Daniel Nadler confirmed to Becker's Hospital Review in September 2026.

Oct 5, 2026

OpenEvidence Is Now Valued at 15 Billion Dollars

L Catterton The Owner of SignatureMD Is Betting on Fertility.

L Catterton, the consumer-focused investment firm that bought SignatureMD, also became a co-lead investor in US Fertility. Its investments connect concierge medicine and fertility care through an owner with experience in branding and consumer demand.

Sep 9, 2026

L Catterton The Owner of SignatureMD Is Betting on Fertility.

Metriport Raised $26M to Pull Outside Medical Records in Seconds: How Your Concierge Doctor Gets Your History

Metriport raised $26 million on August 27, 2026 to pull a patient's outside medical records into a doctor's chart in seconds.[1] TJ Parker, a general partner at Matrix, led the round, with ARTIS Ventures and Y Combinator participating.

Aug 29, 2026

Metriport Raised $26M to Pull Outside Medical Records in Seconds: How Your Concierge Doctor Gets Your History

Sword Health Is Buying Headspace for Up to $300M After a $3B Valuation

Sword Health plans to buy Headspace for between $200 million and $300 million in cash, according to Axios.[1] Headspace's parent company, OrangeDot, confirmed the proposed all-cash transaction in a Massachusetts regulatory filing.

Aug 28, 2026

Sword Health Is Buying Headspace for Up to $300M After a $3B Valuation

Cityblock Buys Homeward to Build a 250,000-Member Primary-Care Platform

Cityblock Health has agreed to buy Homeward Health. This creates a primary-care company that would serve roughly 250,000 people if the deal closes.

Aug 20, 2026

Cityblock Buys Homeward to Build a 250,000-Member Primary-Care Platform

The $150 Line: The HSA Rule That May Reprice Direct Primary Care

The $150 Line: The HSA Rule That May Reprice Direct Primary Care There is now a federal line running directly through direct primary care pricing: $150 per month . As of January 1, 2026, a qualifying direct primary care (DPC) membership at or below $150 preserves a patient's ability to contribute to a Health Savings Account (HSA).

Aug 19, 2026

The $150 Line: The HSA Rule That May Reprice Direct Primary Care

Abridge Moves Beyond AI Scribes Into Clinical Decisions

Abridge built its business by listening to doctor-patient conversations and turning them into medical notes. Now it is moving one step closer to the medical decision itself.

Aug 17, 2026

Abridge Moves Beyond AI Scribes Into Clinical Decisions

An AI Renewed Your Prescription. Doctors Agreed 91% of the Time.

Utah has published the first outcome numbers from its experiment with artificial intelligence (AI) prescription renewals. Doctronic's AI recommended renewing a medication in 72% of requests.

Aug 10, 2026

An AI Renewed Your Prescription. Doctors Agreed 91% of the Time.

Retatrutide Expanded Access Is Open. Here Is Who Actually Qualifies

What is retatrutide? Retatrutide is an experimental weight-loss medication being developed by Eli Lilly.

Aug 6, 2026

Retatrutide Expanded Access Is Open. Here Is Who Actually Qualifies

Function Health Secures $450M In Funding Led By General Catalyst

Function Health is a consumer health platform that gives members access to more than 160 laboratory tests a year. Its $365 membership includes repeat testing, a dashboard for tracking results, written explanations, and clinician review.

Jul 31, 2026

Function Health Secures $450M In Funding Led By General Catalyst
Page 1 of 5